Efficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia is a research paper published in International Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCATS NIH HHS
Grant: UL1 TR003096
NCATS NIH HHS
Grant: UL1 TR001453
NCATS NIH HHS
Grant: UL1 TR002345
NCATS NIH HHS
Grant: UL1 TR002544
NCATS NIH HHS
Grant: U24 TR001579
NCATS NIH HHS
Grant: UL1 TR002377
NCATS NIH HHS
Grant: UL1 TR001998
NCATS NIH HHS
Grant: UL1 TR002553
NCATS NIH HHS
Grant: UL1 TR002645
NCATS NIH HHS
Grant: UL1 TR001881
NCATS NIH HHS
Grant: UL1 TR002366
NCATS NIH HHS
Grant: UM1 TR004406
NHLBI NIH HHS
Grant: R01 HL149683
NCATS NIH HHS
Grant: UL1 TR001445
NCATS NIH HHS
Grant: UL1 TR002319
NCATS NIH HHS
Grant: UL1 TR002489
NCATS NIH HHS
Grant: UL1 TR003017
NCATS NIH HHS
Grant: U24 TR001608
NCATS NIH HHS
Grant: UL1 TR001430
NCATS NIH HHS
Grant: UL1 TR003107
FWCI
1.17
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals